A critical role for type I IFN in arthritis development following Borrelia burgdorferi infection of mice

Journal of Immunology

Volumn 181, Issue 12, 2008, Pages 8492-8503

  Miller, Jennifer C ^a   Ma, Ying ^a   Bian, Jiantao ^a   Sheehan, Kathleen C F ^c   Zachary, James F ^b   Weis, John H ^a   Schreiber, Robert D ^c   Weis, Janis J ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; ALPHA BETA INTERFERON RECEPTOR; BLOCKING ANTIBODY; IFNAR1 PROTEIN, MOUSE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; BORRELIA BURGDORFERI; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE INDUCTION; LYME DISEASE; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; C3H MOUSE; C57BL MOUSE; CELL CULTURE; DENDRITIC CELL; DRUG ANTAGONISM; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES, BLOCKING; BORRELIA BURGDORFERI; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; GENE EXPRESSION PROFILING; IMMUNITY, INNATE; INTERFERON TYPE I; LYME DISEASE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, SCID; RECEPTOR, INTERFERON ALPHA-BETA; SIGNAL TRANSDUCTION;

EID: 58849115951     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.12.8492     Document Type: Article

References (69)

1. Burgdorfer, W., A. G. Barbour, S. F. Hayes, J. L. Benach, E. Grunwaldt, and J. P. Davis. 1982. Lyme disease: a tick-borne spirochetosis? Science 216: 1317-1319.
2. Steere, A. C., and L. Glickstein. 2004. Elucidation of Lyme arthritis. Nat. Rev. Immunol. 4: 143-152.
3. Nocton, J. J., and A. C. Steere. 1995. Lyme disease. Adv. Intern. Med. 40: 69-117.
4. Steere, A. C., R. T. Schoen, and E. Taylor. 1987. The clinical evolution of Lyme arthritis. Ann. Intern. Med. 107: 725-731.
5. Barthold, S. W., D. S. Beck, G. M. Hansen, G. A. Terwilliger, and K. D. Moody. 1990. Lyme borreliosis in selected strains and ages of laboratory mice. J. Infect. Dis. 162: 133-138.
6. Barthold, S. W., D. H. Persing, A. L. Armstrong, and R. A. Peeples. 1991. Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice. Am. J. Pathol. 139: 263-273.
7. Ma, Y., K. P. Seiler, E. J. Eichwald, J. H. Weis, C. Teuscher, and J. J. Weis. 1998. Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice. Infect. Immun. 66: 161-168. (Pubitemid 28018815)
8. Brown, C. R., and S. L. Reiner. 1999. Genetic control of experimental Lyme arthritis in the absence of specific immunity. Infect. Immun. 67: 1967-1973. (Pubitemid 29144423)
9. Barthold, S. W., C. L. Sidman, and A. L. Smith. 1992. Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodefi- ciency. Am. J. Trop. Med. Hyg. 47: 605-613.
10. Wooten, R. M., and J. J. Weis. 2001. Host-pathogen interactions promoting in- flammatory Lyme arthritis: use of mouse models for dissection of disease processes. Curr. Opin. Microbiol. 4: 274-279.
11. Wooten, R. M., Y. Ma, R. A. Yoder, J. P. Brown, J. H. Weis, J. F. Zachary, C. J. Kirschning, and J. J. Weis. 2002. Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi. J. Immunol. 168: 348-355.
12. Bolz, D. D., R. S. Sundsbak, Y. Ma, S. Akira, C. J. Kirschning, J. F. Zachary, J. H. Weis, and J. J. Weis. 2004. MyD88 plays a unique role in host defense but not arthritis development in Lyme disease. J. Immunol. 173: 2003-2010.
13. Liu, N., R. R. Montgomery, S. W. Barthold, and L. K. Bockenstedt. 2004. Myeloid differentiation antigen 88 deficiency impairs pathogen clearance but does not alter inflammation in Borrelia burgdorferi-infected mice. Infect. Immun. 72: 3195-3203. (Pubitemid 38697740)
14. Behera, A. K., E. Hildebrand, R. T. Bronson, G. Perides, S. Uematsu, S. Akira, and L. T. Hu. 2006. MyD88 deficiency results in tissue-specific changes in cytokine induction and inflammation in interleukin-18-independent mice infected with Borrelia burgdorferi. Infect. Immun. 74: 1462-1470.
15. Crandall, H., D. M. Dunn, Y. Ma, R. M. Wooten, J. F. Zachary, J. H. Weis, R. B. Weiss, and J. J. Weis. 2006. Gene expression profiling reveals unique pathways associated with differential severity of Lyme arthritis. J. Immunol. 177: 7930-7942. (Pubitemid 44846309)
16. -/- mice. FEMS Immunol. Med. Microbiol. 52: 124-133.
17. Brown, C. R., and S. L. Reiner. 1999. Experimental Lyme arthritis in the absence of interleukin-4 or gamma interferon. Infect. Immun. 67: 3329-3333. (Pubitemid 29291499)
18. Wilson, L. E., D. Widman, S. H. Dikman, and P. D. Gorevic. 2002. Autoimmune disease complicating antiviral therapy for hepatitis C virus infection. Semin. Arthritis Rheum. 32: 163-173. (Pubitemid 36043715)
19. Strueby, L., B. Nair, A. Kirk, and R. M. Taylor-Gjevre. 2005. Arthritis and bursitis in multiple sclerosis patients treated with interferon-β. Scand. J. Rheumatol. 34: 485-488. (Pubitemid 43062207)
20. Crow, M. K., K. A. Kirou, and J. Wohlgemuth. 2003. Microarray analysis of interferon-regulated genes in SLE. Autoimmunity 36: 481-490. (Pubitemid 37498244)
21. Blanco, P., A. K. Palucka, M. Gill, V. Pascual, and J. Banchereau. 2001. Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus. Science 294: 1540-1543. (Pubitemid 33063928)
22. 1 but not in BALB/c mice. J. Immunol. 174: 2499-2506.
23. Santiago-Raber, M. L., R. Baccala, K. M. Haraldsson, D. Choubey, T. A. Stewart, D. H. Kono, and A. N. Theofilopoulos. 2003. Type-I interferon receptor defi- ciency reduces lupus-like disease in NZB mice. J. Exp. Med. 197: 777-788.
24. Gattorno, M., L. Chicha, A. Gregrio, F. Ferlito, F. Rossi, D. Jarrossay, A. Lanzavecchia, A. Martini, and M. G. Manz. 2007. Distinct expression pattern of IFNα and TNFα in juvenile idiopathic arthritis synovial tissue. Rheumatology 46: 657-665. (Pubitemid 46523313)
25. Salazar, J. C., C. D. Pope, T. J. Sellati, H. M. Feder, Jr., T. G. Kiely, K. R. Dardick, R. L. Buckman, M. W. Moore, M. J. Caimano, J. G. Pope, et al. 2003. Coevolution of markers of innate and adaptive immunity in skin and peripheral blood of patients with erythema migrans. J. Immunol. 171: 2660-2670.
26. Werts, C., R. I. Tapping, J. C. Mathison, T. Chuang, V. Kravchenko, I. Saint Girons, D. A. Haake, P. J. Godowski, F. Hayashi, A. Ozinsky, et al. 2001. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat. Immunol. 2: 346-352. (Pubitemid 33706346)
27. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9: 143-150. (Pubitemid 28361303)
28. Barbour, A. G. 1984. Isolation and cultivation of Lyme disease spirochetes. Yale J. Biol. Med. 57: 521-525. (Pubitemid 15151039)
29. Yang, L., J. H. Weis, E. Eichwald, C. P. Kolbert, D. H. Persing, and J. J. Weis. 1994. Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues. Infect. Immun. 62: 492-500. (Pubitemid 24033768)
30. Sheehan, K. C., K. S. Lai, G. P. Dunn, A. T. Bruce, M. S. Diamond, J. D. Heutel, C. Dungo-Arthur, J. A. Carrero, J. M. White, P. J. Hertzog, and R. D. Schreiber. 2006. Blocking monoclonal antibodies specific for mouse IFN-α/β receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection. J. Interferon Cytokine Res. 26: 804-819.
31. Sheehan, K. C., J. Calderon, and R. D. Schreiber. 1988. Generation and characterization of monoclonal antibodies specific for the human IFN-γ receptor. J. Immunol. 140: 4231-4237. (Pubitemid 18172805)
32. Schreiber, R. D., L. J. Hicks, A. Celada, N. A. Buchmeier, and P. W. Gray. 1985. Monoclonal antibodies to murine γ-interferon which differentially modulate macrophage activation and antiviral activity. J. Immunol. 134: 1609-1618.
33. Habu, S., H. Fukui, K. Shimamura, M. Kasai, Y. Nagai, K. Okumura, and N. Tamaoki. 1981. In vivo effects of anti-asialo GM1 I: reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J. Immunol. 127: 34-38. (Pubitemid 11075445)
34. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299.
35. Morrison, T. B., J. J. Weis, and C. T. Wittwer. 1998. Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Bio- Techniques 24: 954-962.
36. Kagari, T., H. Doi, and T. Shimozato. 2002. The importance of IL-1β and TNF-α, and the noninvolvement of IL-6, in the development of monoclonal antibody- induced arthritis. J. Immunol. 169: 1459-1466. (Pubitemid 34809191)
37. Ornstein, K., and A. G. Barbour. 2006. A reverse transcriptase-polymerase chain reaction assay of Borrelia burgdorferi 16S rRNA for highly sensitive quantifi- cation of pathogen load in a vector. Vector Borne Zoonotic Dis. 6: 103-112.
38. Morrison, T. B., Y. Ma, J. H. Weis, and J. J. Weis. 1999. Rapid and sensitive quantification of Borrelia burgdorferi-infected mouse tissues by continuous fluorescent monitoring of PCR. J. Clin. Microbiol. 37: 987-992.
39. Meerpohl, H. G., M. L. Lohmann-Matthes, and H. Fischer. 1976. Studies on the activation of mouse bone marrow-derived macrophages by the macrophage cytotoxicity factor (MCF). Eur. J. Immunol. 6: 213-217.
40. Manning, B. M., E. Y. Enioutina, D. M. Visic, A. D. Knudson, and R. A. Daynes. 2001. CpG DNA functions as an effective adjuvant for the induction of immune responses in aged mice. Exp. Gerontol. 37: 107-126.
41. Barbour, A. G., S. L. Tessier, and W. J. Todd. 1983. Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody. Infect. Immun. 41: 795-804.
42. Okano, F., M. Merad, K. Furumoto, and E. G. Engleman. 2005. In vivo manipulation of dendritic cells overcomes tolerance to unmodified tumor-associated self antigens and induces potent antitumor immunity. J. Immunol. 174: 2645-2652. (Pubitemid 40279678)
43. Ganapamo, F., V. A. Dennis, and M. T. Philipp. 2000. Early induction of gamma interferon and interleukin-10 production in draining lymph nodes from mice infected with Borrelia burgdorferi. Infect. Immun. 68: 7162-7165. (Pubitemid 32463437)
44. + cells produce IFN-γ in mice infected with Borrelia burgdorferi. Eur. J. Immunol. 31: 3460-3468.
45. Shanafelt, M. C., I. Kang, S. W. Barthold, and L. K. Bockenstedt. 1998. Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathway. Infect. Immun. 66: 266-271. (Pubitemid 28018829)
46. Glickstein, L., B. Moore, T. Bledsoe, N. Damle, V. Sikand, and A. C. Steere. 2003. Inflammatory cytokine production predominates in early Lyme disease in patients with erythema migrans. Infect. Immun. 71: 6051-6053. (Pubitemid 37205660)
47. Leber, J. H., G. T. Crimmins, S. Raghavan, N. P. Meyer-Morse, J. S. Cox, and D. A. Portnoy. 2008. Distinct TLR- and NLR-mediated transcriptional responses to an intracellular pathogen. PLoS Pathog. 4: e6.
48. Indraccolo, S., U. Pfeffer, S. Minuzzo, G. Esposito, G. Roni, S. Mandruzzato, N. Ferrari, L. Anfosso, R. Dell'Eva, D. M. Noonan, et al. 2007. Identification of genes selectively regulated by IFNs in endothelial cells. J. Immunol. 178: 1122-1135. (Pubitemid 46095185)
49. MacMicking, J. D. 2004. IFN-inducible GTPases and immunity to intracellular pathogens. Trends Immunol. 25: 601-609. (Pubitemid 39369737)
50. Keane-Myers, A., and S. P. Nickell. 1995. Role of IL-4 and IFN-γ in modulation of immunity to Borrelia burgdorferi in mice. J. Immunol. 155: 2020-2028.
51. Matyniak, J. E., and S. L. Reiner. 1995. T helper phenotype and genetic susceptibility in experimental Lyme disease. J. Exp. Med. 181: 1251-1254.
52. Colonna, M., G. Trinchieri, and Y. J. Liu. 2004. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5: 1219-1226.
53. Tailor, P., T. Tamura, and K. Ozato. 2006. IRF family proteins and type I interferon induction in dendritic cells. Cell Res. 16: 134-140. (Pubitemid 43247968)
54. Poltorak, A., X. He, I. Smirnova, M. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, M. Freudenberg, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in the Tlr4 gene. Science 282: 2085-2088. (Pubitemid 29001265)
55. Moore, M. W., A. R. Cruz, C. J. LaVake, A. L. Marzo, C. H. Eggers, J. C. Salazar, and J. D. Radolf. 2007. Phagocytosis of Borrelia burgdorferi and Treponema pallidum potentiates innate immune activation and induces gamma interferon production. Infect. Immun. 75: 2046-2062.
56. Brown, C. R., and S. L. Reiner. 1998. Activation of natural killer cells in arthritissusceptible but not arthritis-resistant mouse strains following Borrelia burgdorferi infection. Infect. Immun. 66: 5208-5214.
57. Roper, R. J., J. J. Weis, B. A. McCracken, C. B. Green, Y. Ma, K. S. Weber, D. Fairbairn, R. J. Butterfield, M. R. Potter, J. F. Zachary, et al. 2001. Genetic control of susceptibility to experimental Lyme arthritis is polygenic and exhibits consistent linkage to multiple loci on chromosome 5 in four independent mouse crosses. Genes Immun. 2: 388-397.
58. Weis, J. J., B. A. McCracken, Y. Ma, D. Fairbairn, R. J. Roper, T. B. Morrison, J. H. Weis, J. F. Zachary, R. W. Doerge, and C. Teuscher. 1999. Identification of quantitative trait loci governing arthritis severity and humoral responses in the murine model of Lyme disease. J. Immunol. 162: 948-956.
59. Glickstein, L., M. Edelstein, and J. Z. Dong. 2001. Gamma interferon is not required for arthritis resistance in the murine Lyme disease model. Infect. Immun. 69: 3737-3743. (Pubitemid 32493292)
60. Takaoka, A., and H. Yanai. 2006. Interferon signalling network in innate defence. Cell. Microbiol. 8: 907-922. (Pubitemid 43670834)
61. Gil, M. P., E. Bohn, A. K. O'Guin, C. V. Ramana, B. Levine, G. R. Stark, H. W. Virgin, and R. D. Schreiber. 2001. Biologic consequences of Stat1-independent IFN signaling. Proc. Natl. Acad. Sci. USA 98: 6680-6685.
62. Ramana, C. V., M. P. Gil, Y. Han, R. M. Ransohoff, R. D. Schreiber, and G. R. Stark. 2001. Stat1-independent regulation of gene expression in response to IFN-γ. Proc. Natl. Acad. Sci. USA 98: 6674-6679. (Pubitemid 32538275)
63. Schroder, K., P. J. Hertzog, T. Ravasi, and D. A. Hume. 2004. Interferon-γ: an overview of signals, mechanisms and functions. J. Leukocyte Biol. 75: 163-189. (Pubitemid 38174573)
64. Platanias, L. C. 2005. Mechanisms of type-I- and type-II-interferon- mediated signalling. Nat. Rev. Immunol. 5: 375-386.
65. Brown, C. R., V. A. Blaho, K. L. Fritsche, and C. M. Loiacono. 2006. Stat1 deficiency exacerbates carditis but not arthritis during experimental Lyme borreliosis. J. Interferon Cytokine Res. 26: 390-399.
66. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801.
67. Solomon, S., N. Rajasekaran, E. Jeisy-Walder, S. B. Snapper, and H. Illges. 2005. A crucial role for macrophages in the pathology of K/B X N serum-induced arthritis. Eur. J. Immunol. 35: 3064-3073. (Pubitemid 41555102)
68. Shin, O. S., R. R. Isberg, S. Akira, S. Uematsu, A. K. Behera, and L. T. Hu. 2008. Distinct roles for MyD88 and Toll-like receptors 2, 5, and 9 in phagocytosis of Borrelia burgdorferi and cytokine induction. Infect. Immun. 76: 2341-2351.
69. Gratz, N., M. Siller, B. Schaljo, Z. A. Pirzada, I. Gattermeier, I. Vojtek, C. J. Kirschning, H. Wagner, S. Akira, E. Charpentier, and P. Kovarik. 2008. Group A Streptococcus activates type I interferon production and MyD88-dependent signaling without involvement of TLR2, TLR4, and TLR9. J. Biol. Chem. 283: 19879-19887.